Cambridge Major Laboratories and AAIPharma Services announced their intent to merge. Financial terms of the merger were not disclosed. The move is intended to build a global supplier of integrated CMC services. Patrick Walsh, chief executive officer of AAIPharma, will hold that role in the merged company. Brian Scanlan, chief executive officer and president of CML, will be president of Business Operations at the combined company, handling sales, marketing and other customer-facing roles. The n...